CNBC Pro used earnings data from Bespoke Investment Group to find companies that have a history of beating analyst estimates and subsequently rising in price.
A norovirus vaccine could be on the horizon as cases rise
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.